SOME ASPECTS OF IMPROVING ADHERENCE TO DUAL ANTITHROMBOTIC THERAPY AFTER ACUTE CORONARY SYNDROME
The current clinical guidelines for the treatment of patients with acute coronary syndrome (ACS) claim that simultaneous use of two drugs that inhibit platelet activity is mandatory for most patients. This approach known as dual antiplatelet therapy (DAT), in view of the similarity of the mechanisms...
Main Author: | |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«REMEDIUM GROUP» Ltd.
2017-05-01
|
Series: | Атеротромбоз |
Subjects: | |
Online Access: | https://www.aterotromboz.ru/jour/article/view/108 |